A recent case report highlights the importance of understanding the possibility of the development of Euglycemic diabetic ...

Patients with type 1 or type 2 diabetes who experience nausea, vomiting, or malaise or develop a metabolic acidosis in the setting of SGLT-2 inhibitor therapy should be promptly evaluated for the ...

Karen Roach, RVT, VTS (ECC), discusses her education session about diabetic ketoacidosis, presented at the 2024 Fetch Coastal conference in Atlantic City, New Jersey. Karen Roach, RVT, VTS (ECC), a ...

Prolonged hyperglycemia (high blood sugar) and diabetic ketoacidosis (DKA) can increase your risk of developing thrombosis ...

Oct. 31, 2024 — Children who experienced sugar restrictions during their first 1,000 days after conception had up to 35% lower risk of developing type 2 diabetes and as much as 20% less risk of ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a class of oral diabetes medications that have multiple indications and benefits for patients with heart failure and chronic kidney disease. These ...

Close to 10% of the Canadian population have been diagnosed with diabetes. The most common form is Type 2, or non-insulin ...

Type 1 and type 2 diabetes can lead to the vision-threatening condition known as diabetic retinopathy. High blood sugar in poorly controlled diabetes can damage vessels in the light-sensing retina in ...

Type 2 diabetes and obesity are intimately linked; reduction of bodyweight improves glycemic control, mortality and morbidity. Treating obesity in the diabetic is hampered as some diabetic ...

These include: Signs of lactic acidosis such as fatigue, muscle pain, trouble breathing, or stomach pain. Signs of hypoglycemia such as shakiness or dizziness. Keep in mind that hypoglycemia is more ...